148 related articles for article (PubMed ID: 32982446)
21. LncRNA HULC promotes the progression of gastric cancer by regulating miR-9-5p/MYH9 axis.
Liu T; Liu Y; Wei C; Yang Z; Chang W; Zhang X
Biomed Pharmacother; 2020 Jan; 121():109607. PubMed ID: 31726371
[TBL] [Abstract][Full Text] [Related]
22. LncRNA PTCSC3 suppressed cervical carcinoma cell invasion and proliferation via regulating miR-574-5p.
Zhang M; Song Y; Yu L
Am J Transl Res; 2019; 11(11):7186-7194. PubMed ID: 31814920
[TBL] [Abstract][Full Text] [Related]
23. LncRNA HULC promotes non-small cell lung cancer cell proliferation and inhibits the apoptosis by up-regulating sphingosine kinase 1 (SPHK1) and its downstream PI3K/Akt pathway.
Liu L; Zhou XY; Zhang JQ; Wang GG; He J; Chen YY; Huang C; Li L; Li SQ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8722-8730. PubMed ID: 30575912
[TBL] [Abstract][Full Text] [Related]
24. Long Non-Coding RNA HULC Promotes Progression of Bone Neoplasms.
Zhang T; Wan CY; Mei XL; Jia P; Wang MJ
Med Sci Monit; 2018 Aug; 24():5754-5760. PubMed ID: 30120220
[TBL] [Abstract][Full Text] [Related]
25. [Effect of long non-coding RNA highly upregulated in liver cancer on the biological behavior of oral squamous cell carcinoma].
Su W; Wang YF; Wang F; Yang HJ; Yang HY
Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 Nov; 53(11):760-765. PubMed ID: 30419657
[No Abstract] [Full Text] [Related]
26. Human bone marrow mesenchymal stem cell-driven LncRNA PTCSC3 upregulation within lung adenocarcinoma cells reduces erlotinib resistance by mitigating Wnt/β-Catenin pathway.
Chen B; Zhang B; García Cenador MB
Am J Cancer Res; 2024; 14(5):2439-2452. PubMed ID: 38859830
[TBL] [Abstract][Full Text] [Related]
27. LncRNA PTCSC3 affects drug resistance of anaplastic thyroid cancer through STAT3/INO80 pathway.
Wang XM; Liu Y; Fan YX; Liu Z; Yuan QL; Jia M; Geng ZS; Gu L; Lu XB
Cancer Biol Ther; 2018 Jul; 19(7):590-597. PubMed ID: 29561707
[TBL] [Abstract][Full Text] [Related]
28. Long Non-Coding RNA HULC Promotes Cervical Cancer Cell Proliferation, Migration and Invasion via miR-218/TPD52 Axis.
Lu W; Wan X; Tao L; Wan J
Onco Targets Ther; 2020; 13():1109-1118. PubMed ID: 32103980
[TBL] [Abstract][Full Text] [Related]
29. LncRNA MIR100HG promotes cancer cell proliferation, migration and invasion in laryngeal squamous cell carcinoma through the downregulation of miR-204-5p.
Huang Y; Zhang C; Zhou Y
Onco Targets Ther; 2019; 12():2967-2973. PubMed ID: 31114240
[No Abstract] [Full Text] [Related]
30. Effect of lncRNA HULC knockdown on rat secreting pituitary adenoma GH3 cells.
Rui QH; Ma JB; Liao YF; Dai JH; Cai ZY
Braz J Med Biol Res; 2019; 52(4):e7728. PubMed ID: 30994730
[TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA-ZNF281 promotes cancer cell migration and invasion in gastric cancer via downregulation of microRNA-124.
Gao H; Li P; Hei Y; Li S; Wang J; Lv X; Zhang J
Oncol Lett; 2020 Mar; 19(3):1849-1855. PubMed ID: 32194679
[TBL] [Abstract][Full Text] [Related]
32. MiRNA-124 inhibits the proliferation, migration and invasion of cancer cell in hepatocellular carcinoma by downregulating lncRNA-UCA1.
Zhao B; Lu Y; Cao X; Zhu W; Kong L; Ji H; Zhang F; Lin X; Guan Q; Ou K; Zhang X; Chen Q
Onco Targets Ther; 2019; 12():4509-4516. PubMed ID: 31354286
[No Abstract] [Full Text] [Related]
33. Circular RNA-ITCH Inhibits the Proliferation of Ovarian Carcinoma by Downregulating lncRNA HULC.
Yan H; Xiang H; Sun B; Feng F; Chen P
Reprod Sci; 2020 Jan; 27(1):375-379. PubMed ID: 32046413
[TBL] [Abstract][Full Text] [Related]
34. LncRNA POU3F3 Promotes Cancer Cell Proliferation, Migration, and Invasion in Renal Cell Carcinoma by Downregulating LncRNA GAS5.
Zhang L; Wang C; Ma M
Kidney Blood Press Res; 2021; 46(5):613-619. PubMed ID: 34352801
[TBL] [Abstract][Full Text] [Related]
35. LncRNA CASC11 promotes the cervical cancer progression by activating Wnt/beta-catenin signaling pathway.
Hsu W; Liu L; Chen X; Zhang Y; Zhu W
Biol Res; 2019 Jun; 52(1):33. PubMed ID: 31255182
[TBL] [Abstract][Full Text] [Related]
36. LncRNA WT1-AS downregulates lncRNA UCA1 to suppress non-small cell lung cancer and predicts poor survival.
Wan Y; Yao D; Fang F; Wang Y; Wu G; Qian Y
BMC Cancer; 2021 Jan; 21(1):104. PubMed ID: 33514344
[TBL] [Abstract][Full Text] [Related]
37. The lncRNA LINC00675 regulates cell proliferation, migration, and invasion by affecting Wnt/β-catenin signaling in cervical cancer.
Ma S; Deng X; Yang Y; Zhang Q; Zhou T; Liu Z
Biomed Pharmacother; 2018 Dec; 108():1686-1693. PubMed ID: 30372871
[TBL] [Abstract][Full Text] [Related]
38. LncRNA GASL1 inhibits tumor growth in gastric carcinoma by inactivating the Wnt/β-catenin signaling pathway.
Peng C; Li X; Yu Y; Chen J
Exp Ther Med; 2019 May; 17(5):4039-4045. PubMed ID: 30988785
[TBL] [Abstract][Full Text] [Related]
39. Quantitative Proteomics Analysis Indicates That Upregulation of lncRNA HULC Promotes Pathogenesis of Glioblastoma Cells.
Hu Y; Ye S; Li Q; Yin T; Wu J; He J
Onco Targets Ther; 2020; 13():5927-5938. PubMed ID: 32606802
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of long non-coding RNA RP11-363E7.4 inhibits proliferation and invasion in gastric cancer.
Chen C; Wang X; Liu T; Tang X; Liu Y; Liu T; Zhu J
Cell Biochem Funct; 2020 Oct; 38(7):921-931. PubMed ID: 32141108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
